DENTSPLY SIRONA Inc. (XRAY) Profit Margins
Over the twelve months to 2026-06-30, DENTSPLY SIRONA Inc. (XRAY) had gross margin 49.5%, operating margin -8.5%, net margin -15.0%, free cash flow margin 3.9%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
XRAYDENTSPLY SIRONA Inc.Follow XRAY — free
—
Price chart with a free account
- Market cap
- 1.9B
- P/E TTM
- —
- Dividend yield
- 6.8%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 51.2% | 50.9% | 50.2% | 53.1% | 53.5% | 54.7% | 56.7% | 53.4% | 54.8% | 51.9% | 53.8% | 49.6% | 55.5% | 54.2% | 52.6% | 51.6% | 50.0% | 49.5% | |
| Operating margin | 17.7% | 17.1% | 11.9% | 13.0% | 14.2% | 15.2% | 14.0% | 12.1% | -39.1% | -24.0% | 8.8% | -0.1% | 14.4% | -23.9% | -2.1% | -23.2% | -11.5% | -8.5% | |
| Net margin | 12.7% | 12.0% | 9.6% | 10.7% | 10.6% | 11.0% | 9.4% | 11.5% | -38.8% | -25.4% | 6.4% | -2.2% | 9.7% | -24.2% | -3.3% | -24.0% | -16.3% | -15.0% | |
| FCF margin | 14.2% | 15.0% | 12.7% | 9.5% | 10.8% | 15.8% | 15.9% | 11.7% | 11.5% | 8.0% | 12.8% | 16.8% | 12.2% | 9.4% | 5.8% | 7.4% | 2.8% | 3.9% |
USD billions · SEC XBRL
DENTSPLY SIRONA Inc. — questions
- What is DENTSPLY SIRONA Inc.'s gross margin?
- 49.5% over the twelve months to 2026-06-30.
- What is DENTSPLY SIRONA Inc.'s operating margin?
- -8.5% over the twelve months to 2026-06-30.
- What is DENTSPLY SIRONA Inc.'s net profit margin?
- -15.0% over the twelve months to 2026-06-30.
Every figure on this page comes from DENTSPLY SIRONA Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.